ILK and breast cancer: Using another ILK inhibitor, known as T315, in MDA-MB-468 BC cells which exhibit elevated expression of ILK, Lee, et al. [52] demonstrated that ILK inhibition resulted in reduced phosphorylation of Ser473-Akt.